drugset / Trial / NCT03617718

Summary

This study is testing a non invasive way to measure airway pH in individuals with Asthma and Cystic Fibrosis using a new inhaled drug. The airway pH will help health care providers in creating tailored treatment plans for individuals suffering from these specific conditions.

Timeline

Start
2018-11-01
Primary completion
2025-07-16
Completion
2025-07-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Glycine Buffer Unknown — Inhaled

Indications